Sanofi, GlaxoSmithKline start new COVID-19 vaccine study after failed trial
February 22, 2021
The drugmakers pushed back the rollout of their experimental COVID-19 shot in December because a study found it generated an “insufficient” immune response to the virus in people older than 50 years. Read More
Posted in Uncategorized